R.M. Santos

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Human epidermal growth factor receptor 2 (HER2) has been evaluated in breast cancer patients to identify those most likely to benefit from herceptin-targeted therapy. HER2 amplification, detected in 20-30% of invasive breast tumors, is associated with reduced survival and metastasis. The most frequently used technique for evaluating HER2 protein status as a(More)
  • 1